Skip to content

Health insurance often pushes abortion pills that harm one in 10 women, with serious physical damage  

‘Unlike health insurance, Health Care Sharing Ministries won’t pay for drugs and procedures that kill babies and put women in extreme danger,’ said AHCSM Executive Director Katy Talento

 

WASHINGTON — A new study has revealed that 10.93% of women experience sepsis, infection, hemorrhaging or another serious adverse event within 45 days following a mifepristone (abortion pill) abortion.

 

“The real-world rate of serious adverse events following mifepristone abortions is at least 22 times as high as the summary figure of ‘less than 0.5 percent’ in clinical trials reported on the drug label,” the researchers say.

 

“Studies like this show just how corrupt health insurance and government programs are by pushing a pro-abortion agenda on women and giving them ‘the safe and effective abortion pill’ when these medications are far too dangerous to be left on the market,” said Katy Talento, executive director of the Alliance of Health Care Sharing Ministries.

 

“Unlike health insurance, Health Care Sharing Ministries won’t facilitate the sharing of expenses arising from drugs and procedures that kill babies and put women in extreme danger. If women and those who love them knew that they had a one in ten chance of bleeding out on their bathroom floor or ending up in the ER, a good number would run as far as they could from this poison.

 

“The increasing dangers and immorality rampant in the so-called ‘health care’ system suggest that it is all the more important for Christians to band together to support each other through communities such as Health Care Sharing Ministries — the only 100% pro-life option for financing medical bills,” said Talento.

 

Conducted by the Ethics and Public Policy Center, this largest-known study of the abortion pill is based on an analysis of data from an all-payer insurance claims database that includes 865,727 prescribed mifepristone abortions from 2017 to 2023.

 

“Danco Laboratories markets Mifeprex as ‘the safe and effective abortion pill,’ but our research shows that mifepristone abortion, as currently practiced in the U.S., is not safe and effective,” the study says. “The manufacturer and the FDA rely on the results of 10 clinical trials with a total of 30,966 participants, less than 0.5 percent of whom reportedly experienced serious adverse reactions.”

 

“In contrast, we analyzed real-world insurance claims data for 865,727 prescribed mifepristone abortions, broadly representative of women who obtain mifepristone abortions in the U.S. today, and we find a serious adverse event rate of 10.93 percent — at least 22 times as high as the summary figure reported on the drug label. Women deserve better than the abortion pill.”

 

Nearly two-thirds of American women who pursue abortion are now using abortion pills rather than surgery to end their pregnancies, according to the pro-abortion Guttmacher Institute.

 

About 642,700 pregnancies — 63% of all abortions recorded in the health care system — were terminated in 2023 using abortion pills. That is up from 53% in 2020.

 

“Why is this happening? The system and the leaders of the system have left women to administer their own abortions alone in their bathrooms,” Talento said. “Big Pharma has gotten exactly what it wanted from the FDA — an unregulated Amazon of abortion pills — illegally mailed across state lines in record numbers.”

 

The Food and Drug Administration approved mifepristone for abortions back in 2000, but required a doctor visit at its administration and shortly thereafter to try to protect mothers from the drug’s most serious harms — harms that the drug’s manufacturer grossly underreported. But the FDA, under both the Obama and Biden administrations, eliminated all requirements for in-person doctor visits, and the data showing increased utilization of these dangerous drugs shows the impact of looser regulation that allows for pills to be mailed across the country without any medical care of the women taking the pill, including checking to see if the drug is even indicated using gestational staging, screening for ectopic pregnancies, or even simple checks that the customer isn’t a man seeking to poison a woman against her will.

 

“Women should have the ongoing care of a doctor when taking a high-risk drug,” Talento said. “The FDA betrayed women and girls when it removed the necessary in-person doctor visits that protected women’s health and well-being. The FDA recklessly endangered women’s health by removing the safety standards it once provided to women using these hazardous drugs.”

 

Founded in 2007 and headquartered in Washington, D.C., the Alliance of Health Care Sharing Ministries is a 501(c)(6) trade organization representing the common interests of Health Care Sharing Ministries which are facilitating the sharing of health care needs (financial, emotional, and spiritual) by individuals and families, and their participants. The Alliance engages with federal and state regulators, members of the media, and the Christian community to provide accurate and timely information on health care sharing.

 

To learn more about the Alliance of Health Care Sharing Ministries, visit www.ahcsm.org or follow the ministry on Facebook or Twitter.

 

 

Leave a Comment